Aug 10, 2020 7:30 am EDT VolitionRx Limited Schedules Second Quarter 2020 Earnings Conference Call and Business Update
Jul 14, 2020 6:00 am EDT Volition Announces Promising Clinical Trials Results for its Novel COVID-19 Triage Test
Jun 25, 2020 8:45 am EDT VolitionRx Releases Business Update Video and Announces Addition to the Russell 3000® and Russell Microcap® Indexes
May 27, 2020 8:45 am EDT Volition Announces Cameron Reynolds, President and Chief Executive Officer Invited as Presenter at Maxim's COVID-19 Virtual Conference
May 22, 2020 4:01 pm EDT VolitionRx Announces Closing of $13.8 Million Public Offering of Common Stock
May 20, 2020 8:45 am EDT VolitionRx Announces Pricing of Underwritten Public Offering of Common Stock
May 13, 2020 5:00 pm EDT VolitionRx To Present First Data on Nu.Q™ Capture Performance and Nu.Q™ Assay Performance in Lung Cancer and Blood Cancer at the 2020 ASCO Annual Meeting
May 7, 2020 4:10 pm EDT VolitionRx Limited Announces First Quarter 2020 Financial Results and Business Update
May 5, 2020 8:30 am EDT VolitionRx Limited Schedules First Quarter 2020 Earnings Conference Call and Business Update
